Literature DB >> 28259997

Non‑coding RNAs and ovarian diseases (Review).

Dandan Li1, Duo Xu2, Yinggang Zou1, Ying Xu1, Lulu Fu1, Xin Xu1, Yongzheng Liu1, Xueying Zhang1, Jingshun Zhang1, Hao Ming1, Lianwen Zheng1.   

Abstract

Non-coding RNAs (ncRNAs) are a diverse family of untranslated transcripts, which serve important roles in numerous biological processes. ncRNAs are emerging as major mediators of gene expression with crucial regulatory functions. Ovarian diseases have a wide variety of clinical pathological types, which have serious impacts on women's health. In this review, current studies on ncRNAs are summarized with respect to ovarian diseases. Understanding of the role of ncRNAs in ovarian diseases is currently limited; further studies on the molecular mechanisms by which abnormal expression of ncRNAs contributes to ovarian diseases will aid in the identification of ncRNAs as novel diagnostic markers and therapeutic targets for ovarian diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259997     DOI: 10.3892/mmr.2017.6176

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Long non-coding RNA placenta‑specific protein 2 regulates micorRNA-19a/tumor necrosis factor α to participate in polycystic ovary syndrome.

Authors:  Gang Li; Yongli Wang; Jingyuan Wang; Gong Chen; Haiyan Wang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

2.  Identification of potential key circular RNAs related to cognitive impairment after chronic constriction injury of the sciatic nerve.

Authors:  Changliang Liu; Rui Gao; Yidan Tang; Hai Chen; Xueying Zhang; Yalan Sun; Qi Zhao; Peilin Lv; Haiyang Wang; Shixin Ye-Lehmann; Jin Liu; Chan Chen
Journal:  Front Neurosci       Date:  2022-08-18       Impact factor: 5.152

Review 3.  Impact of Endocrine Disruptors upon Non-Genetic Inheritance.

Authors:  Debbie Montjean; Anne-Sophie Neyroud; Marina G Yefimova; Moncef Benkhalifa; Rosalie Cabry; Célia Ravel
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.